NSCI — Nanalysis Scientific Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual cashflow statement for Nanalysis Scientific, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	C2022 December 31st	C2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-3.68	-1.77	-9.91	-16.8	-13.6
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items	0.303	0.569	1.86	3.87	11.1
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	1.28	-2.56	-4.41	-2.92	1.26
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities	-0.623	-1.2	-8.55	-11.2	3.26
Capital Expenditures	-2.9	-3	-7.2	-4.59	-1.86
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-1.21	-0.343	-4.29	-1.46	0.168
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-4.11	-3.35	-11.5	-6.06	-1.69
Financing Cash Flow Items	0	10.2	13.8	2.88	3.21
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	1.27	11.8	13.2	14.5	-0.956
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-3.46	7.25	-6.88	-2.77	0.617